Bio-Techne's market cap is currently $8.25B. The company's EPS TTM is $0.53; its P/E ratio is 115.48; and it has a dividend yield of 0.63%. Bio-Techne is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $0.42. See an overview of income statement, balance sheet, and cash flow financials.
